This session, created by the International Society for Cell & Gene Therapy (ISCT) in collaboration with the Society for Immunotherapy of Cancer (SITC), will focus on mechanisms of tumor resistance to targeted cellular cancer therapy and how to address that resistance.
International Society for Cell and Gene Therapy (ISCT) is a growing global society of clinicians, regulators, researchers, technologists and industry partners. ISCT is the global leader focused on pre-clinical and translational aspects of developing cell-based therapeutics, thereby advancing scientific research into innovative treatments for patients.
The ISCT meeting occurred May 29 - June 1, 2019 in Melbourne, Australia. ISCT-SITC Joint Session: Mechanisms of Tumor Resistance to Targeted Cellular Cancer Therapy
Speakers for the session are as follows:
Kenneth P. Micklethwaite, MBBS, PhD, FRACP, FRCPA
Haematologist and Blood and Marrow Transplant Physician, Westmead Hospital
Cassian Yee, MD*
Professor, MD Anderson Cancer Center, United States
Timothy Cripe, MD, PhD
Division Chief, Nation Wide Children's Hospital, United States
Hideho Okada, MD, PhD*
Professor, UCSF, United States
*Denotes SITC speaker representative.
For more information and daily recaps, please click here.